1UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland. 2Systems Biology Ireland, UCD School of Medicine, University College Dublin, ...
A committee of three scientists named by the CEBP Editor-in-Chief selects the Award winner each year based on the committee’s evaluation of the following criteria: originality; scientific, clinical, ...
Cancer Res (2022) 82 (12_Supplement): 3595. Combination treatment with RMC-6291 and SHP2 or SOS1 inhibitors was well tolerated in preclinical models and further increased anti-tumor activity, likely ...
1Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. *Corresponding Author: Cari M. Kitahara, Division of ...
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.
Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.
1Baylor College of Medicine, Houston, TX.
Cancer Res (2025) 85 (8_Supplement_1): 6376.
1Adult Stem Cell Research Center and Research Institute for Veterinary Science, Seoul, Republic of Korea.
Cancer Res (2024) 84 (17_Supplement): B012.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback